Questa pagina è stata tradotta automaticamente e l'accuratezza della traduzione non è garantita. Si prega di fare riferimento al Versione inglese per un testo di partenza.

AI in SK Histopathological Diagnosis (AI\SK)

23 agosto 2026 aggiornato da: Hebatullah Fouad Mahmoud Elkerm, Al-Azhar University

Evaluation of Artificial Intelligence Algorithms Performance in the Histopathological Diagnosis of Seborrheic Keratosis

The aim of this study is to evaluate the diagnostic performance of an Artificial Intelligence (AI) algorithm in the histopathological diagnosis of Seborrheic keratosis compared to Certified Dermatopathologists.

Panoramica dello studio

Stato

Non ancora reclutamento

Descrizione dettagliata

Seborrheic keratosis (SK) is one of the most common benign epidermal tumors. Treatment is generally unnecessary, although lesions may be removed because of irritation, pruritus, or cosmetic concerns. SK has several clinical and histological subtypes, including common seborrheic keratosis (CSK), which is more prevalent among Caucasians, and dermatosis papulosa nigra (DPN), which is more common in individuals with Fitzpatrick skin phototypes III and above. Its development is associated mainly with age and genetic predisposition, with possible contribution from ultraviolet radiation. Lesions may occur almost anywhere except the palms and soles, with the face and upper trunk being common sites. Diagnosis is usually clinical but may be supported by dermoscopy or histopathology.

Histologically, SK represents an intraepidermal proliferation of squamous or basaloid cells. The characteristic findings include acanthosis, papillomatosis, hyperkeratosis, keratin cysts, and keratin pseudocysts. Cellular atypia is generally absent, while the amount of melanin and melanocytes varies according to the degree of pigmentation. SK shows considerable clinical and histological variability, which can sometimes make differentiation from other lesions, such as keratoacanthoma and clear cell acanthoma, challenging.

Recent advances in digital pathology and artificial intelligence (AI) have created new opportunities for diagnostic support in dermatopathology. AI aims to mimic aspects of human intelligence, while machine learning enables computers to identify patterns from data. Deep learning, neural networks, and convolutional neural networks (CNNs) are particularly important in image analysis. AI in dermatopathology has evolved from early text-based systems such as TEGUMENT, introduced in 1987, to modern systems capable of directly analyzing digital pathology images. Although widespread clinical implementation is still developing, AI has potential applications in diagnosis, triage, education, and research and requires collaboration between dermatopathologists, pathologists, clinicians, engineers, and data scientists.

Study Methodology

H&E-stained glass slides will be collected from the Al-Hussein dermatopathology archive, covering the period from 2010 to 2019. A panel of certified dermatopathologists will evaluate the slides. Their diagnoses will serve as the gold standard against which the AI results will be compared.

The slides will be digitized using a Leica Aperio GT450 scanner at 40× magnification. Before scanning, slides will be cleaned and assessed for adequate staining, proper coverslipping, and absence of artifacts such as air bubbles, tissue folds, or debris. The scanner can accommodate 15 racks with 30 slides per rack, for a total of 450 slides per run, with approximately 1.5-2 minutes required to scan each slide.

Whole Slide Images (WSIs) will be generated and stored in SVS format, with individual file sizes typically ranging from approximately 500 MB to 2 GB. The digital slides will then undergo quality control using Aperio ImageScope to ensure adequate focus, clarity, and complete tissue capture. Suboptimal slides will be rescanned. The images will subsequently be transferred to an external hard drive for storage and backup before being uploaded to the HistoGPT cloud platform for AI analysis.

HistoGPT Analysis

The WSIs will be analyzed using HistoGPT, a Vision-Language Model for Digital Pathology. Because WSIs are extremely large, they are first divided into smaller image patches or tiles, typically 256×256 or 512×512 pixels. Tissue detection is then performed to exclude background areas and focus the analysis on the tissue.

HistoGPT uses a Vision Transformer (ViT) and a Hierarchical Vision Transformer (HiViT) to extract histological features at multiple scales. This allows the model to identify both microscopic features, such as cellular atypia and mitotic figures, and larger architectural patterns, such as symmetry, circumscription, and infiltrative growth.

Through attention mechanisms, the model can also establish relationships between spatially distant areas of the slide and recognize the importance of tissue organization and anatomical location. Its cross-modal alignment allows visual histological features to be associated with terminology used in pathology reports, enabling recognition of concepts such as keratin pearls, clefting, and solar elastosis.

Finally, the language component of HistoGPT generates a structured pathology report, potentially including a microscopic description, differential diagnosis, and final diagnosis. The AI-generated reports will be compared with the reports and diagnoses produced by the dermatopathology experts, and the time required for the diagnostic process will also be assessed.

Statistical Analysis

The collected data will be analyzed using SPSS version 26.0 or R programming. A p-value < 0.05 will be considered statistically significant. Overall, the study aims to evaluate the diagnostic performance and time efficiency of HistoGPT in dermatopathology by comparing its findings with expert dermatopathologists serving as the gold standard.

Tipo di studio

Osservativo

Iscrizione (Stimato)

30

Contatti e Sedi

Questa sezione fornisce i recapiti di coloro che conducono lo studio e informazioni su dove viene condotto lo studio.

Contatto studio

Luoghi di studio

      • Cairo, Egitto
        • Faculty of medicine, Al-Azhar University boys branch in Cairo
        • Contatto:

Criteri di partecipazione

I ricercatori cercano persone che corrispondano a una certa descrizione, chiamata criteri di ammissibilità. Alcuni esempi di questi criteri sono le condizioni generali di salute di una persona o trattamenti precedenti.

Criteri di ammissibilità

Età idonea allo studio

  • Bambino
  • Adulto
  • Adulto più anziano

Accetta volontari sani

No

Metodo di campionamento

Campione non probabilistico

Popolazione di studio

Seborrheic keratosis H&E stained glass slides from the pathology archive of Al-hussein dermatopathology unit.

Descrizione

Inclusion Criteria:

  1. Histopathological slides diagnosed as Seborrheic keratosis.
  2. Slides with adequate staining and preservation allowing clear visualization of histopathological features.

Exclusion Criteria:

  1. Slides with poor staining quality or significant artifacts interfering with histopathological interpretation.
  2. Slides that were damaged, faded, or inadequately preserved.
  3. Cases with uncertain or inconclusive original diagnoses.
  4. Slides that could not be successfully digitized due to technical limitations ex: very short or too long slides.

Piano di studio

Questa sezione fornisce i dettagli del piano di studio, compreso il modo in cui lo studio è progettato e ciò che lo studio sta misurando.

Come è strutturato lo studio?

Dettagli di progettazione

Cosa sta misurando lo studio?

Misure di risultato primarie

Misura del risultato
Lasso di tempo
The accuracy of the artificial intelligence algorithm in histopathological diagnosis of seborrheic keratosis evaluated mainly by sensitivity and specificity.
Lasso di tempo: 1 year
1 year

Collaboratori e investigatori

Qui è dove troverai le persone e le organizzazioni coinvolte in questo studio.

Studiare le date dei record

Queste date tengono traccia dell'avanzamento della registrazione dello studio e dell'invio dei risultati di sintesi a ClinicalTrials.gov. I record degli studi e i risultati riportati vengono esaminati dalla National Library of Medicine (NLM) per assicurarsi che soddisfino specifici standard di controllo della qualità prima di essere pubblicati sul sito Web pubblico.

Studia le date principali

Inizio studio (Stimato)

1 ottobre 2026

Completamento primario (Stimato)

1 ottobre 2027

Completamento dello studio (Stimato)

1 dicembre 2027

Date di iscrizione allo studio

Primo inviato

23 agosto 2026

Primo inviato che soddisfa i criteri di controllo qualità

23 agosto 2026

Primo Inserito (Effettivo)

26 agosto 2026

Aggiornamenti dei record di studio

Ultimo aggiornamento pubblicato (Effettivo)

26 agosto 2026

Ultimo aggiornamento inviato che soddisfa i criteri QC

23 agosto 2026

Ultimo verificato

1 agosto 2026

Maggiori informazioni

Termini relativi a questo studio

Altri numeri di identificazione dello studio

  • 303 (Klein Buendel, Inc.)

Informazioni su farmaci e dispositivi, documenti di studio

Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti

No

Studia un dispositivo regolamentato dalla FDA degli Stati Uniti

No

Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .

Sottoscrivi